Full Text View
Tabular View
No Study Results Posted
Related Studies
Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
This study has been completed.
Study NCT00072215   Information provided by National Cancer Institute (NCI)
First Received: November 4, 2003   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Extragonadal Germ Cell Tumor
Testicular Germ Cell Tumor
Additional conditions recognized in this trial
Neoplasms, Germ Cell and Embryonal
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
filgrastim
pegfilgrastim
cisplatin
ifosfamide
paclitaxel
vinblastine
Additional drug interventions recognized in this trial
Isophosphamide mustard
More general drug interventions related to this trial
Alkylating Agents
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Cancer and Leukemia Group B
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services